Zai Lab (NASDAQ:ZLAB) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.55) by 92.73 percent. This is a 92.73 percent increase over losses of $(0.55) per share from the same period last year. The company reported quarterly sales of $106.49 million which missed the analyst consensus estimate of $116.76 million by 8.80 percent. This is a 22.19 percent increase over sales of $87.15 million the same period last year.